Vascular Resections during Curative Surgery for Pancreatic Adenocarcinoma
The Pancreatic Adenocarcinoma (PA) is estimated to become the second leading cancer-related death cause by 2030. At the time of diagnosis, 30% of patients have a locally advanced disease especially vascular involvement Performed firstly in 1973; the benefits of vein resection on survival have been clearly demonstrated by published reports